iCVA
PI
Trivia
Ethos
Kronos
Respiratory Medications
100

1 in 4 patients died within ___ year after a COPD hospitalization.

What is 1 year

100

Breztri is administered via inhalation at this frequency for optimal maintenance treatment

 What is 2 inhalataions, 2x day

100

The year Breztri launched.

2020

100

The primary endpoint in ETHOS study

Rate of mod/sever COPD exacerbations over 52 weeks

100

This combination inhaler contains budesonide, glycopyrrolate and Formoterol to manage COPD Symptoms. 

What is Breztri
200

Breztri is the ONLY triple therapy to prevent _____ or _____ exacerbations with a 18% reduction vs ICS/LABA.

What is moderate or severe

200

Breztri should not be used for this type of respiratory event, which requires a quick-relief medication.

What is acute bronchospasm

200

This test measures the amount of air a person can exhale in one second and is used to diagnose COPD. 

Spriometry

200

The primary endpoint in KRONOS study

FEV1 for Breztri vs BUD/FORM MDI and change from the baseline in morning pre-dose trough or severe COPD exacerbations. 

200

Breztri is prescribed to patients with this chronic respiratory condition characterized by airflow limitation.

What is COPD

300

The all-cause mortality data was a predefined secondary endpoint in this study.

What is ETHOS

300

This indicator display has a pointer which will move after every actuation.  When nearing the end of the usable inhalations, the pointer is in the yellow zone and should be discarded when in the red zone.  

What is the dose counter
300

Breztri is delivered using this type of inhaler, which releases a fine mist of medication for inhalation.

What is a pressurized metered-dose inhaler

300

T or F

The current Gold Report supports the use of ICS/LABA for initial or follow-up treatment of COPD.

False

The Gold Report does not support the use of ICS/LABA for initial follow-up treatment of COPD

300

Formoterol, one of the components in Breztri, belongs to this class of medications, which helps relax the muscles around the airways. 

What is Long-acting beta-agonists (LABA)
400

For every ____ patients treated over a year, Breztri could prevent 1 additional moderate or severe exacerbations vs ICS/LABA?

What is 7

400

Patients using Breztri should rinse their mouth after each use to prevent this oral fungal infection. 

**Bonus if you can explain the process of rinsing the actuator.**

What is thrush (oral candidiasis)

**Remove canister, remove mouthpiece cover, run warm water through mouthpiece for 30 sec and then through the actuator for 30 sec, shake off water, let air dry.


400

Breztri may cause this cardiovascular side effect, characterized by a faster-than-normal heart rate.

What is tachycardia

400
Identify 2 patient characteristics for the KRONOS study.

1. Majority of patients did not have a history of moderate or severe COPD exacerbations within the past year

2. Mean age: 65 years old

3. approx 90% had moderate or severe COPD

4. 40% current smoker

400

This corticosteroid in Breztri helps reduce inflammation in the lungs, improving breathing. 

What is Budesonide
500

On the current ICVA summary page, the three main talking points are...

What is...

52% reduction in mod/sever exacerbations vs LAMA/LABA.

For ever 7 patients treated over a year, Breztri could prevent 1 additional mod/severe exacerbation vs ICS/LABA.

Time to All-Cause Mortality

500

The process used to mix medicine and propellant, spraying it into the air, to ensure the inhaler is ready to use and delivers the correct dose of medicine


What is Priming

Before 1st use- remove mouthpiece, shake inhaler well and spray 1 test-puff into the air facing away from you. Repeat for a total of 4 test-puffs shaking the inhaler before each test puff.

500

Patients with this eye condition, involving increased pressure in the eye, should use Breztri with caution. 

What is glaucoma

500

What are the top 3 adverse reactions to Breztri?

What is upper respiratory tract infection, pneumonia, back pain

500

Glycopyrrolate in Breztri acts as this type of agent, blocking the effect of acetycholine on muscarinic receptors.  

What is anticholinergic

M
e
n
u